Search Press releases Keywords From To 1 Jul 2019 Transparency notifications BlackRock, Inc. Read More 27 Jun 2019 UCB and Amgen Provide Regulatory Update on Status of EVENITY® (romosozumab) in the EU Read More 24 Jun 2019 Transparency notifications BlackRock, Inc. Read More 13 Jun 2019 UCB’s Key Pipeline Molecule Bimekizumab Demonstrated Improved Outcomes for Ankylosing Spondylitis Patients Read More 12 Jun 2019 Transparency notifications BlackRock, Inc. Read More 6 Jun 2019 UCB Showcases the Depth of its Immunology Research and Commitment to Patients at EULAR 2019 Read More Pagination First page Previous page Previous … Page 58 Page 59 Page 60 Page 61 Current page 62 Page 63 Page 64 Page 65 Page 66 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
